Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Race Strategic Update August 2023 2023-08-09 07:30
Race executes agreement with Ardena for GMP manufacturing of RC220 2023-07-13 07:30
Race executes agreement with Ardena for GMP manufacturing of RC220 2023-07-12 19:30
Race executes global license agreement with City of Hope to access FTO IP 2023-07-11 07:30
Race executes global license agreement with City of Hope to access FTO IP 2023-07-10 19:30
Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech 2021-11-22 09:24
Zantrene® kills melanoma cancer cells that overproduce FTO 2021-09-30 11:58
Race Oncology Signs Exclusive License Agreement with BL&H Korea for the Sale of Bisantrene, an Agent for Treating Acute Myelogenous Leukemia, in South Korea 2017-04-03 07:01
1